Abstract
In order to reduce toxicity of methotrexate and improve bioavailability, permeability, and explore other delivery routes, a proline prodrug of methotrexate was synthesized and preformulation stability studies were conducted under accelerated conditions to assess compound liability and possible conversion to the parent drug. Forced degradation studies showed that the prodrug will degrade in the presence of water, acid, and heat (70 °C), generating the parent compound methotrexate. It was also found that this conversion is temperature dependent. In addition, the prodrug is extremely light and oxidative labile. Therefore, future formulation studies should be light protected and stabilized by a suitable antioxidant. It was also found that the prodrug is stable in the HPLC diluent, consisting of water and acetonitrile; stored bench-top and protected from light for up to two weeks.
Keywords: Preformulation, Stability, Forced degradation, Hydrolysis, Methotrexate, Proline, Prodrug, acetonitrile, MTX, Amethopterin
Medicinal Chemistry
Title:The Preformulation Stability Studies of a Proline Prodrug of Methotrexate
Volume: 8 Issue: 4
Author(s): Ann Stephenson, Zhiqian Wu and Xudong Yuan
Affiliation:
Keywords: Preformulation, Stability, Forced degradation, Hydrolysis, Methotrexate, Proline, Prodrug, acetonitrile, MTX, Amethopterin
Abstract: In order to reduce toxicity of methotrexate and improve bioavailability, permeability, and explore other delivery routes, a proline prodrug of methotrexate was synthesized and preformulation stability studies were conducted under accelerated conditions to assess compound liability and possible conversion to the parent drug. Forced degradation studies showed that the prodrug will degrade in the presence of water, acid, and heat (70 °C), generating the parent compound methotrexate. It was also found that this conversion is temperature dependent. In addition, the prodrug is extremely light and oxidative labile. Therefore, future formulation studies should be light protected and stabilized by a suitable antioxidant. It was also found that the prodrug is stable in the HPLC diluent, consisting of water and acetonitrile; stored bench-top and protected from light for up to two weeks.
Export Options
About this article
Cite this article as:
Stephenson Ann, Wu Zhiqian and Yuan Xudong, The Preformulation Stability Studies of a Proline Prodrug of Methotrexate, Medicinal Chemistry 2012; 8 (4) . https://dx.doi.org/10.2174/157340612801216166
DOI https://dx.doi.org/10.2174/157340612801216166 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Progress in Stem Cell Research and its Potential for Islet Cell Transplantation
Current Molecular Medicine The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Characterisation of Bacillus subtilis Transcriptional Regulators Involved in Metabolic Processes
Current Protein & Peptide Science Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout
Infectious Disorders - Drug Targets Neuroimmune Aspects of Sjogren`s Syndrome: Role of VIP/VPAC System in Immune and Salivary Gland Epithelial Cell Function
Current Pharmaceutical Design Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease
CNS & Neurological Disorders - Drug Targets Lipoxygenases (LOs): An Heterogenous Family of Lipid Peroxidizing Enzymes Implicated in Cell Differentiation, Inflammation, Asthma, Carcinogenesis, Atherogenesis-An Interesting Target for the Development of Promising Drugs
Current Enzyme Inhibition Taking Cell Culture in Drug Discovery to the Third Dimension - A Patent Review
Recent Patents on Biomedical Engineering (Discontinued) Nigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A Review
Current Pharmaceutical Biotechnology Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy
Mini-Reviews in Medicinal Chemistry Perspectives of Fullerenes, Dendrimers, and Heterocyclic Compounds Application in Tumor Treatment
Recent Patents on Nanomedicine Editorial: [Hot Topics: Metabolism and Drug-Drug Interaction Potential of Biotherapeutics]
Current Drug Metabolism Aminoacid Support in the Prevention of Diabetes and Diabetic Complications
Current Protein & Peptide Science COVID-19 and Renal Diseases: An Update
Current Drug Targets Novel Epigenetic Targets in Lymphoproliferative Disorders
Current Cancer Drug Targets Nucleic Acids Electro-transfer: From Bench to Bedside
Current Drug Metabolism Effect of Some Triterpene Glycosides Applied in vitro on Chromatin State in Human Cells
Current Bioactive Compounds Medicinal Plants Towards Modeling Skin Cancer
Current Drug Targets The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases
Current Medicinal Chemistry